Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

SOLTAMOX

TAMOXIFEN CITRATE

Standard Dose
EQ 20MG BASE/10ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SOLTAMOX is listed in Drugs@FDA under application 021807 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TAMOXIFEN CITRATE Form and strength SOLUTION;ORAL - EQ 20MG BASE/10ML Sponsor MAYNE PHARMA COMMRCL Submission history Latest submission status date: 2019-04-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview SOLTAMOX is listed in Drugs@FDA under application 021807 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TAMOXIFEN CITRATE Form and strength SOLUTION;ORAL - EQ 20MG BASE/10ML Sponsor MAYNE PHARMA COMMRCL Submission history Latest submission status date: 2019-04-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.